Health Companies
Trial Library ๐บ๐ธ 
Verily ๐บ๐ธ 
Nyra Health ๐ฆ๐น 
Mindoo ๐ง๐ช 
Smile Genius ๐ฎ๐ช 
GE HealthCare ๐บ๐ธ 
Spotlight Pathology ๐ฌ๐ง 
Healthplus.ai ๐ 
Relation Therapeutics ๐ 
Nitra ๐ Latest Deals in Health
$21.6M
Vienna-based digital health company Nyra Health has raised โฌ20 million in Series A funding to expand its AI-powered neurotherapy platform internationally and accelerate product development. The funding round was led by Armira Growth, with participation from Wellington Partners, Crane Venture Partners, and Ever Pharma.Investors: Armira Growth, Wellington Partners, Crane Venture Partners, Ever Pharma
$21.6M
Vienna-based Nyra Health has raised โฌ20 million in Series A funding to expand its AI-powered neurological therapy platform across the DACH region and the United States. The funding round was led by Armira Growth, with support from Wellington Partners, Crane Venture Partners, and Ever Pharma. Nyra Health aims to improve access to individualized care for those affected by neurological conditions, addressing gaps in therapy after hospital discharge. Its product, MyReha, is already integrated into over 100 rehabilitation clinics and reimbursed by 28 health insurers, reaching over 40 million insured individuals.Investors: Armira Growth, Wellington Partners, Crane Venture Partners, Ever Pharma
$25.4M
Brainomix, an Oxford, UK-based company, raised $6.5 million in Series C extension funding, bringing the total to $25.4 million. The funding round was led by Parkwalk and Hostplus via the IP Group Hostplus Innovation Fund, with participation from new U.S.-based investor Modi Ventures. The company develops AI-powered imaging tools for stroke and lung fibrosis.
BRAINOMIXInvestors: Parkwalk, Hostplus, Modi Ventures
$23.5M
Brainomix, an Oxford-based biotech firm, has extended its Series C funding round with an additional ยฃ4.8 million investment, bringing the total to ยฃ18.8 million. This funding will enhance its U.S. operations and support the deployment of its AI imaging platforms, Brainomix 360 Stroke and e-Lung, which address acute stroke assessment and pulmonary fibrosis, respectively. The investment was led by existing investors Parkwalk Advisors and Hostplus, with participation from new investor Modi Ventures.Investors: Parkwalk Advisors, Hostplus, Modi Ventures
$20M
Flinn, a pan-European AI-powered regulatory and quality automation software company for medtech and pharma, has secured an additional $20 million in funding to enhance automation throughout the medical and pharmaceutical product lifecycle. The funding round was led by HV Capital, with participation from US-based BHI โ Bertelsmann Healthcare Investments, along with continued support from Cherry Ventures, Speedinvest, and SquareOne.
FLINNInvestors: HV Capital, BHI โ Bertelsmann Healthcare Investments, Cherry Ventures, Speedinvest, SquareOne
MEDIKARMA
$20M
Flinn.ai, a software development startup based in Vienna, Austria, raised $20 million in Series A funding to automate regulatory and quality workflows for medtech companies. The funding round was led by HV Capital, with participation from Bertelsmann Healthcare Investments, Cherry Ventures, Speedinvest, and SquareOne. The company plans to use the funds to expand its operations and development efforts.Investors: HV Capital, Bertelsmann Healthcare Investments, Cherry Ventures, Speedinvest, SquareOne
PATIENTDESK AI
$4.32M
Frederiksberg-based healthtech startup Hemi Health has raised โฌ4 million in seed funding to support its international expansion, starting with the Netherlands. The funding round was led by Denmarkโs Export and Investment Fund (EIFO) and Swiss Health Ventures, with participation from existing investors. Hemi Health provides structured, outcome-driven treatment for patients with migraines, headache disorders, and concussions, utilizing a proprietary digital platform for personalized care. The company has already supported over 1,000 patients and aims to integrate with insurance systems to enhance care pathways.
HEMI HEALTHInvestors: Export and Investment Fund (EIFO), Swiss Health Ventures
$0.446875M
Pontiro, a healthtech company, has raised ยฃ357,500 in a funding round led by SFC Capital, with participation from Plug and Play Ventures and the British Business Bank. The funding addresses the bottleneck in healthcare AI by enabling safe and compliant use of medical imaging data for research. The investment will support Pontiro's expansion beyond Wales into NHS England trusts, facilitating the sharing of anonymised datasets while protecting patient privacy.
PONTIROInvestors: SFC Capital, Plug and Play Ventures, British Business Bank
$0.00044625M
Pontiro, a healthtech company, has raised ยฃ357,500 in a funding round led by SFC Capital, with participation from Plug and Play Ventures and the British Business Bank. The company addresses the bottleneck in healthcare AI by automating the preparation of medical imaging data for research, significantly reducing turnaround times and compliance risks. With over 2 million medical images processed, the funding will support Pontiro's expansion from NHS Wales to NHS England trusts, enhancing AI evaluation frameworks in healthcare.Investors: SFC Capital, Plug and Play Ventures, British Business Bank
$0.44625M
Pontiro, a Welsh healthtech company, has raised ยฃ357,500 to enhance the safe use of medical imaging data for research and AI. The funding round was led by SFC Capital, with participation from Plug and Play Ventures and the British Business Bank. Pontiro's platform has processed over 2 million medical images, automating secure anonymization and AI validation. The investment will support expansion into NHS England trusts and the development of an AI evaluation platform to provide evidence of AI performance in clinical settings.Investors: SFC Capital, Plug and Play Ventures, British Business Bank
$45M
ten63 therapeutics has secured strategic investment from Chugai Venture Fund and the Gates Foundation, raising its total funding to over $45 million. This funding will aid in the development of its proprietary Beyond platform, which is the first large quantum chemistry model capable of simulating trillions of potential drugs per protein with near laboratory-level accuracy.
TEN63 THERAPEUTICSInvestors: Chugai Venture Fund, Gates Foundation
RAINFALL HEALTH
$2M
SpendRule, a Dallas, Texas-based startup, has raised $2 million to develop a contract intelligence platform aimed at preventing overpayments in hospital finance, particularly for purchased services lacking clear receipts. The funding round was led by Abundant Venture Partners, with participation from MemorialCare Innovation Fund and Zeal Capital Partners. The platform addresses a $32 billion annual overpayment issue by enforcing contract terms in real time, targeting a complex $300+ billion market. Early customers include Kettering Health and MUSC Health.
SPENDRULEInvestors: MemorialCare Innovation Fund, Zeal Capital Partners, Abundant Venture Partners
$20M
Vienna-based Flinn, an AI-powered software provider, has secured $20 million in follow-on funding to automate regulatory and quality processes in medtech. The funding round was led by HV Capital, with participation from Bertelsmann Healthcare Investments and continued support from Cherry Ventures, Speedinvest, and SquareOne. Flinn's software addresses challenges in healthcare by replacing manual workflows with scalable solutions, enhancing operational efficiency and compliance for medtech manufacturers. The new capital will help extend its platform and support international growth, particularly in Europe and the US.Investors: HV Capital, Bertelsmann Healthcare Investments, Cherry Ventures, Speedinvest, SquareOne
CUSTOM SURGICAL